Tof-MRM for the Confirmation of Fentanyl Analogues for Forensic Toxicology

Importance of the Topic

Detection and confirmation of fentanyl analogues in biological samples are critical in forensic toxicology due to the high potency and evolving nature of these compounds. Enhanced analytical specificity and sensitivity enable reliable identification at trace levels, supporting public health and legal investigations.

Objectives and Study Overview

This study evaluated a targeted acquisition approach, Tof-MRM, on a quadrupole time-of-flight instrument for confirmatory analysis of fentanyl analogues in urine. A secondary aim was to apply Threshold Accurate Calibration (TAC) to normalize matrix effects without relying on deuterated internal standards.

Methodology and Instrumentation

Samples (calibrators, QCs, and cases) were prepared in a 96-well plate by adding urine aliquots in paired “neat” and “spiked” wells, followed by dilution with mobile phase. Chromatographic separation used an ACQUITY UPLC I-Class system with an HSS C18 column and a 15-minute gradient.

Key instrument details:

• Mass spectrometer: Xevo G2-XS QTof with electrospray ionization in positive mode
• Data processing: UNIFI Scientific Information System
• Acquisition mode: Tof-MRM monitoring dual transitions per analyte
• Sample volume: 5 µL injection from 87% aqueous/13% organic mobile phase

Key Results and Discussion

Initial comparisons showed 5- to 20-fold sensitivity gains for Tof-MRM versus non-targeted MS^E. The approach resolved structural isomers and achieved limits of detection in the sub-ng/mL range using a simple dilution protocol. Validation over 17 runs demonstrated acceptable precision and accuracy at concentrations of 0.8, 1.5, 3.0, and 10.0 ng/mL. In 25 authentic case samples, Tof-MRM confirmation matched a separate UPLC-MS/MS screening in all instances, detecting fentanyl, norfentanyl, beta-hydroxyfentanyl, 4-ANPP, and other analogues.

Benefits and Practical Applications

The combined Tof-MRM and TAC strategy offers:

• Superior specificity and sensitivity for trace-level fentanyl analogues
• Simplified in-well sample preparation without solid-phase extraction
• Matrix normalization without deuterated internal standards
• Adaptability to emerging analogues and streamlined method updates

Future Trends and Potential Applications

Ongoing trends include integration of targeted and non-targeted HRMS workflows for comprehensive drug surveillance, expansion of TAC to additional analyte classes, and development of automated data interpretation tools. Portable high-resolution MS platforms may enable on-site forensic analysis in the near future.

Conclusion

The described Tof-MRM confirmatory method, combined with TAC, provides a robust and sensitive protocol for forensic urine analysis of fentanyl analogues. Its high concordance with established screening techniques, simplified sample preparation, and flexibility make it an effective tool for laboratories dealing with evolving synthetic opioids.

References

1. Rosano TG, Wood M, Ihenetu K, Swift TA. Drug Screening in Medical Examiner Casework by High-Resolution Mass Spectrometry (UPLC–MSE-TOF). J Anal Toxicol. 2013;37(8):1–14.
2. Dalsgaard P, et al. Quantitative Analysis of Screening of 30 Drugs in Whole Blood by SPE-UHPLC-TOF-MS. Forensic Sci Criminology. 2013;1(1):1–6.
3. Bidny S, Gago K, Chung P, Albertyn D, Pasin D. Simultaneous Screening and Quantification of Basic, Neutral and Acidic Drugs in Blood Using UPLC-QTOF-MS. J Anal Toxicol. 2017;41(3):181–195.
4. Grapp M, Kaufmann C, Streit F, Binder L. Systematic Forensic Toxicological Analysis by LC-QTOF-MS in Serum and Comparison to GC-MS. Forensic Sci Int. 2018;287:63–73.
5. Rosano TG, Ohouo PY, Wood M. Application of High Resolution UPLC-MSE/TOF for Confirmation in Forensic Urine Drug Screening by UPLC-MS/MS. J Anal Toxicol. 2019; In press.
6. Wood M, Barknowitz G, Goshawk JA, Lee R. Evaluation of Various ToF Acquisition Strategies for Illicit Drugs. TIAFT Conf. 2018.
7. Rosano T, Ohouo P, Wood M. High Resolution MS for Fentanyl Analog Confirmation and Discovery in Forensic Urine. SOFT Minneapolis. 2018.
8. Rosano T, Ohouo P, LeQue J, Freeto S, Wood M. Definitive Drug and Metabolite Screening in Urine by UPLC-MS/MS Using a Novel Calibration Technique. J Anal Toxicol. 2016;40(8):628–638.
9. Rosano T, Ohouo P, Wood M. Screening with Quantification for 64 Drugs and Metabolites in Human Urine using UPLC-MS/MS and Threshold Accurate Calibration. J Anal Toxicol. 2017;41(6):536–546.